Invitrogen™ ARPP21 Polyclonal Antibody

Catalog No.	Quantity
PIPA553580	100 μL

Catalog No. PIPA553580 Supplier Invitrogen™ Supplier No. PA553580

Description

Rabbit Polyclonal Antibody

Immunogen sequence: EQGDLNQAIA EEGGTEQETA TPENGIVKSE SLDEEEKLEL QRRLEAQNQE RRKSKSGAGK GKLTRSLAVC EESSARPGGE SLQDQESIHL QLSSFSSLQE EDKSRKDDSE REKEKDKNKD KTSEKPKIRM LSKDCSQEYT Highest antigen sequence identity to the following orthologs: Mouse - 87%, Rat - 88%.

The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 41-81 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). At least two transcript variants encoding the same protein have been found for this gene.

Specifications

• Antigen: ARPP21
• Applications: Immunohistochemistry (Paraffin)
• Classification: Polyclonal
• Concentration: 0.40 mg/mL
• Conjugate: Unconjugated
• Formulation: PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
• Gene: ARPP21
• Gene Accession No.: Q9UBL0
• Gene Alias: 0710001E13Rik; AI853636; ARPP21; Arpp-21; cAMP regulated phosphoprotein 21; cAMP regulated phosphoprotein 21kDa; cAMP-regulated phosphoprotein (21 kDa); cAMP-regulated phosphoprotein 21; cyclic AMP-regulated phosphoprotein 21; cyclic AMP-regulated phosphoprotein, 21; cyclic AMP-regulated phosphoprotein, 21 kD; D9Bwg1012e; Ppp1r1c; Ppp1r1cl; protein phosphatase 1, regulatory (inhibitory subunit 1C); protein phosphatase 1, regulatory (inhibitory) subunit 1C; protein phosphatase 1, regulatory subunit 1C; R3H domain containing 3; R3HDM3; RCS; Regulator of calmodulin signaling; RGD1307208; RGD1307215; TARPP; thymocyte ARPP; thymocyte cAMP-regulated phosphoprotein
• Gene Symbols: ARPP21
• Host Species: Rabbit
• Immunogen: Recombinant protein corresponding to Human ARPP21. Recombinant protein control fragment (Product #RP-90682).
• Purification Method: Antigen affinity chromatography
• Quantity: 100 μL
• Regulatory Status: RUO
• Primary or Secondary: Primary
• Gene ID (Entrez): 10777
• Target Species: Human
• Content And Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
• Product Type: Antibody
• Form: Liquid
• Isotype: IgG